US NewsDrugmaker Declines FDA Request to Pull Treatment After Patient DeathsSarepta stopped shipping Elevidys to non-ambulatory patients earlier this year.SavePrintThe U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch TimesZachary StieberSenior Reporter7/21/2025|Updated: 7/22/20250:00X 1Update: Sarepta is halting all shipments of Elevidys.Original story below.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.Share this articleLeave a commentZachary StieberSenior ReporterZachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]Author’s Selected ArticlesCollins Launches Bid for 6th Senate TermFeb 10, 2026RFK Jr.-Aligned Group Backs Primary Challenger to Sen. Bill CassidyFeb 10, 2026US Fly Production Plant to Open by End of 2027 to Fight Screwworm: USDAFeb 10, 2026DOJ Seeks Dismissal of Steve Bannon’s Contempt of Congress CaseFeb 09, 2026